Married couples share the risk of diabetes: Study

Agencies
May 24, 2018

London, May 24: Your partner’s body mass index (BMI) can predict your risk of developing diabetes, according to a which found study has found that men are particularly more prone to developing the metabolic disease if their wife obese.

Researchers from University of Copenhagen and Aarhus University in Denmark examined data from 3,649 men and 3,478 women in the UK.

On a global scale, 422 million adults have diabetes according to World Health Organisation (WHO), and it is estimated to cause 1.5 million deaths.

“We have discovered that you can predict a person’s risk of developing type 2 diabetes based on his or her partner’s BMI. This means that you can tell whether a person has a heightened risk or not on the basis of the partner’s BMI,” said Jannie Nielsen, which has been published in the scientific journal Diabetologia.

From other studies the researchers knew that spouses are often similar in terms of body weight, among other things because people often marry someone similar to themselves and often share dietary and exercise habits when living together.

Therefore, the researchers also examined whether the heightened risk of developing type 2 diabetes of an obese woman, for example, was merely a result of her own body weight. Here the researchers found a difference between the two sexes.

“If we adjusted for the women’s own weight, they did not have a heightened risk of developing type 2 diabetes as a result of their husband’s BMI. But even when we adjusted for the weight in men, they had a heightened risk,” said Nielsen.

A man, whose wife had a BMI of 30, had a 21 per cent higher risk of developing diabetes than men whose wives had a BMI of 25 – regardless of the man’s own BMI.

The researchers have not examined why only the men still had a heightened risk after own weight adjustment. They do have a theory, though, which involves who is in charge of the household.

“We believe it is because women generally decide what we eat at home. That is, women have greater influence on their spouse’s dietary habits than men do,” Nielsen said, referring to a previous study, which showed that women more often than men are responsible for doing the household’s cooking and shopping.

Diabetes can cause complications and serious sequelae such as damage to the heart, kidneys and eyes. According to the Danish Diabetes Association, 35 per cent experience complications by the time they are diagnosed with diabetes. Therefore, early detection is vital.

“The earlier a disease is detected, the higher the potential for successful prevention and treatment. We know that type 2 diabetes can be prevented or postponed, reducing the number of years that patients have to live with the disease. Just as related complications can be postponed through early detection,” said Nielsen.

If type 2 diabetes is detected at an early stage, medical treatment can be postponed, and instead the patient can begin with lifestyle changes such as eating a healthy diet and doing more physical exercise.

Based on the study, Nielsen believes that early detection of type 2 diabetes can be improved if we change our approach to the disease.

“Our approach to type 2 diabetes should not focus on the individual, but instead on, for example, the entire household. If a woman has a heightened risk, there is a strong probability that it is shared by her husband,” she said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
January 5,2020

Washington D.C., Jan 5: After a woman filed a lawsuit against a diet soda company, the California court has declared that the beverage does not promise to help buyers in losing weight.

The woman had gulped down the drink for over a decade but did not lose inches as a result.

The three-judge panel declared during the hearing: "The prevalent understanding of the term in (the marketplace) is that the 'diet' version of a soft drink has fewer calories than its 'regular' counterpart."

However, the members of the US 9th circuit court have felt that the consumers tend to make out something of their own that is unreasonable and eventually hamper the reputation of brands through a deceptive allegation, reports Fox News.

The response was due to a misleading case filed against Diet Dr Pepper by Shana Becerra from Santa Rosa, California. Shana claimed that she has been addictively purchasing the low-calorie beverage for the past 13 years hoping for losing some fat but failed to lose even a single inch.

The woman also stated that the attractive and fit models misled her into believing that drink will help her in perfecting her body like them.

However, the court's decision was that advertisements are for representational purposes only. "Cannot be reasonably understood to convey any specific meaning at all," as written by Judge Jay Bybee.

Shana had last week made such allegation against Diet coke as well where the court came to a similar verdict. She claimed that she had found various studies where it is evident that the artificial sweetener aspartame used in diet beverages actually boosts weight gain.

But the artificial sweetener is approved in by the concerned administrative department and thus is used in most American drinks.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
May 26,2020

Tedros Adhanom Ghebreyesus, the World Health Organisation's (WHO) Director-General, said that a clinical trial of hydroxychloroquine (HCQ) on COVID-19 patients has come to "a temporary pause", while the safety data of the the anti-malaria drug was being reviewed.

According to the WHO chief, The Lancet medical journal on May 22 had published an observational study on HCQ and chloroquine and its effects on COVID-19 patients that have been hospitalized, reports Xinhua news agency.

The authors of the study reported that among patients receiving the drug, when used alone or with a macrolide, they estimated a higher mortality rate.

"The Executive Group of the Solidarity Trial, representing 10 of the participating countries, met on Saturday (May 23) and has agreed to review a comprehensive analysis and critical appraisal of all evidence available globally," Tedros said in a virtual press conference on Monday.

The review will consider data collected so far in the Solidarity Trial and in particular robust randomized available data, to adequately evaluate the potential benefits and harms from this drug, he said.

"The Executive Group has implemented a temporary pause of the HCQ arm within the Solidarity Trial while the safety data is reviewed by the Data Safety Monitoring Board. The other arms of the trial are continuing," Tedros added.

WHO initiated the Solidarity Trial, a plan to evaluate the safety and efficacy of four drugs and drug combinations against COVID-19 more than two months ago, which include HCQ.

According to the WHO, over 400 hospitals in 35 countries are actively recruiting patients and nearly 3,500 patients have been enrolled from 17 countries under the Solidarity Trial.

Tedros added that the safety concern over the drug related only to the use of HCQ and chloroquine in COVID-19, and "these drugs are accepted as generally safe for use in patients with autoimmune diseases or malaria".

"WHO will provide further updates as we know more," he added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 27,2020

New Delhi, Mar 27: The Centre has restricted sale and distribution of "hydroxychloroquine" declaring it as an essential drug to treat the COVID-19 patients and meet the requirements of emergency arising due to the pandemic.

The Ministry of Health and Family Welfare on Thursday made the announcement making it clear that the order "shall come into force on the date of its publication in the official Gazette".

In the order, the government declared that the Central government is "satisfied that the drug hydroxychloroquine is essential to meet the requirements of emergency arising due to pandemic COVID-19 and in the public interest, it is necessary and expedient to regulate and restrict the sale and distribution of the drug 'hydroxychloroquine' and preparation based thereon for preventing their misuse".

"Now, therefore, in exercise of the powers conferred by Section 26B of the Drugs and Cosmetics Act, 1940 (23 of 1940), the Central government hereby directs that sale by retail of any preparation containing the drug Hydroxychloroquine shall be in accordance with the conditions for sale of drugs specified in Schedule H1 to the Drugs and Cosmetics Rules, 1945."

The order came at a time when the novel coronavirus claimed 16 lives and infected over 600 people across India.

The announcement regarding ban of sale and distribution of the drug was made by the government earlier but it issued an official Gazette notification on Thursday signalling that hydroxychloroquine -- an anti-Malaria drug -- will work as a medicine for treating coronavirus infected patients as well.

Recently, the national task force for COVID-19 constituted by Indian Council for Medical Research (ICMR) has recommended hydroxy-chloroquine as a preventive medication.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.